Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 18, Issue 2, Pages 175-195
Publisher
Future Medicine Ltd
Online
2016-12-20
DOI
10.2217/pgs-2016-0158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis
- (2016) XiaoBing Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Precursor miR-499a Variant but not miR-196a2 is Associated with Rheumatoid Arthritis Susceptibility in an Egyptian Population
- (2016) Eman A. Toraih et al. Molecular Diagnosis & Therapy
- Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients
- (2016) Patricia Moya et al. PHARMACOGENOMICS
- ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis
- (2016) Niveditha Muralidharan et al. PHARMACOGENOMICS
- Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis
- (2016) Young Ho Lee et al. RHEUMATOLOGY INTERNATIONAL
- Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis
- (2015) Niveditha Muralidharan et al. CLINICAL RHEUMATOLOGY
- Multidrug resistance 1 (MDR1) 3435C>T gene polymorphism influences the clinical phenotype and methotrexate-induced adverse events in South Indian Tamil rheumatoid arthritis
- (2015) Niveditha Muralidharan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway
- (2015) Souhir Chaabane et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy
- (2015) Maciej Tarnowski et al. Expert Opinion on Drug Metabolism & Toxicology
- Methylene tetrahydrofolate reductase genotypes frequencies: association with the toxicity of and response to methotrexate in rheumatoid arthritis patients
- (2015) Mais M. Saleh et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
- (2015) Aurea Lima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis
- (2015) Yogita Ghodke-Puranik et al. PHARMACOGENOMICS
- The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients
- (2015) Tomas Soukup et al. RHEUMATOLOGY INTERNATIONAL
- Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis
- (2015) Y.H. Lee et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis
- (2015) Anthony Usenbo et al. PLoS One
- The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
- (2014) Marita Cross et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis
- (2014) Gwan Gyu Song et al. CLINICAL RHEUMATOLOGY
- Laboratory Biomarkers for Guiding Therapy with Methotrexate in Rheumatoid Arthritis
- (2014) Carlos Abud-Mendoza et al. CURRENT PHARMACEUTICAL DESIGN
- Three decades of low-dose methotrexate in rheumatoid arthritis: Can we predict toxicity?
- (2014) Vasco C. Romão et al. IMMUNOLOGIC RESEARCH
- Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients
- (2014) Sima A. Samara et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate
- (2014) Shiva Prasad et al. International Journal of Rheumatic Diseases
- Determinants of Erythrocyte Methotrexate Polyglutamate Levels in Rheumatoid Arthritis
- (2014) E. den Boer et al. JOURNAL OF RHEUMATOLOGY
- Genetic and epigenetic predictors of responsiveness to treatment in RA
- (2014) Darren Plant et al. Nature Reviews Rheumatology
- Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis
- (2014) Ling Ling Zhang et al. Pharmacogenetics and Genomics
- MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis
- (2014) Michael D Morgan et al. PHARMACOGENOMICS
- Is there a role for the MTHFR 677C>T and 1298A>C polymorphisms in methotrexate-induced liver toxicity?
- (2014) D Maroeska WM te Loo et al. PHARMACOGENOMICS
- Effect of ESR1 and ESR2 gene polymorphisms on rheumatoid arthritis treatment with methotrexate
- (2014) Andrzej Pawlik et al. Pharmacological Reports
- Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients
- (2014) Aurea Lima et al. PLoS One
- SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients
- (2014) Aurea Lima et al. TOXICOLOGICAL SCIENCES
- SLC19A180G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients
- (2013) Aurea Lima et al. PHARMACOGENOMICS
- RFC180G>A Is a Genetic Determinant of Methotrexate Efficacy in Rheumatoid Arthritis: A Human Genome Epidemiologic Review and Meta-Analysis of Observational Studies
- (2013) Tabitha N. Kung et al. Arthritis & Rheumatology
- Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients
- (2012) Biljana Jekic et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetic Polymorphisms Contributing to Toxicity Induced by Methotrexate in the Southern Spanish Population with Rheumatoid Arthritis
- (2012) José Cristian Plaza-Plaza et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients
- (2012) Petra Bohanec Grabar et al. PHARMACOGENOMICS
- Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
- (2012) S A Owen et al. PHARMACOGENOMICS JOURNAL
- Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action
- (2012) Lisa K Stamp et al. ARTHRITIS RESEARCH & THERAPY
- Rheumatoid arthritis
- (2011) Loreto Carmona et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity
- (2011) Kalliopi P. Spyridopoulou et al. Pharmacogenetics and Genomics
- MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms
- (2011) S A Owen et al. PHARMACOGENOMICS JOURNAL
- Methylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in Korean patients with rheumatoid arthritis
- (2011) Jung-Yoon Choe et al. RHEUMATOLOGY INTERNATIONAL
- The C677T polymorphism in theMTHFRgene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population
- (2011) R Cáliz et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway
- (2010) P. B. Grabar et al. ANNALS OF THE RHEUMATIC DISEASES
- Associations between the C677T and A1298C Polymorphisms of MTHFR and the Efficacy and Toxicity of Methotrexate in Rheumatoid Arthritis
- (2010) Young Ho Lee et al. CLINICAL DRUG INVESTIGATION
- PTPN22 1858C>T polymorphism is strongly associated with rheumatoid arthritis but not with a response to methotrexate therapy
- (2010) Edyta Majorczyk et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate
- (2010) Lisa K. Stamp et al. Pharmacogenetics and Genomics
- Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis
- (2010) Wouter M Kooloos et al. PHARMACOGENOMICS
- Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases
- (2010) J P Mena et al. PHARMACOGENOMICS JOURNAL
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Metaanalysis of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms Affecting Methotrexate Toxicity
- (2009) M. C. FISHER et al. JOURNAL OF RHEUMATOLOGY
- Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians
- (2009) Shruti Sharma et al. Pharmacogenetics and Genomics
- Gene–gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis
- (2009) Thierry Dervieux et al. Pharmacogenetics and Genomics
- Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
- (2009) C. Bansard et al. RHEUMATOLOGY
- Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate
- (2009) Y. C. Lee et al. RHEUMATOLOGY
- Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis
- (2008) L K Stamp et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis
- (2008) Judith M. Dalrymple et al. ARTHRITIS AND RHEUMATISM
- Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?
- (2008) Yogita Ghodke et al. CLINICAL RHEUMATOLOGY
- Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism
- (2008) Petra Bohanec Grabar et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX
- (2008) S. L. Hider et al. RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now